196 related articles for article (PubMed ID: 14680061)
1. Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations.
Farsang A; Makranszki L; Dobos-Kovács M; Virág G; Fábián K; Barna T; Kulcsár G; Kucsera L; Vetési F
Acta Vet Hung; 2003; 51(4):493-501. PubMed ID: 14680061
[TBL] [Abstract][Full Text] [Related]
2. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms.
Dalton KP; Nicieza I; de Llano D; Gullón J; Inza M; Petralanda M; Arroita Z; Parra F
Vet Microbiol; 2015 Aug; 178(3-4):208-16. PubMed ID: 26009303
[TBL] [Abstract][Full Text] [Related]
3. Rapid identification of myxoma virus variants by long-range PCR and restriction fragment length polymorphism analysis.
Dalton KP; Ringleb F; Martín Alonso JM; Parra F
J Virol Methods; 2009 Nov; 161(2):284-8. PubMed ID: 19591871
[TBL] [Abstract][Full Text] [Related]
4. Atypical myxomatosis--virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate.
Psikal I; Smíd B; Rodák L; Valícek L; Bendová J
J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):259-64. PubMed ID: 14628995
[TBL] [Abstract][Full Text] [Related]
5. Vaccination strategies against myxomavirus infections: are we really doing the best?
Marlier D
Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
[TBL] [Abstract][Full Text] [Related]
6. Experimental infection of specific pathogen-free New Zealand White rabbits with five strains of amyxomatous myxoma virus.
Marlier D; Cassart D; Boucraut-Baralon C; Coignoul F; Vindevogel H
J Comp Pathol; 1999 Nov; 121(4):369-84. PubMed ID: 10542126
[TBL] [Abstract][Full Text] [Related]
7. A pathogenic myxoma virus in vaccinated and non-vaccinated commercial rabbits.
Kritas SK; Dovas C; Fortomaris P; Petridou E; Farsang A; Koptopoulos G
Res Vet Sci; 2008 Dec; 85(3):622-4. PubMed ID: 18455207
[TBL] [Abstract][Full Text] [Related]
8. Field experimental vaccination campaigns against myxomatosis and their effectiveness in the wild.
Ferreira C; Ramírez E; Castro F; Ferreras P; Alves PC; Redpath S; Villafuerte R
Vaccine; 2009 Nov; 27(50):6998-7002. PubMed ID: 19800438
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
[TBL] [Abstract][Full Text] [Related]
10. Novel bivalent vectored vaccine for control of myxomatosis and rabbit haemorrhagic disease.
Spibey N; McCabe VJ; Greenwood NM; Jack SC; Sutton D; van der Waart L
Vet Rec; 2012 Mar; 170(12):309. PubMed ID: 22266680
[TBL] [Abstract][Full Text] [Related]
11. Myxomatosis in farmland rabbit populations in England and Wales.
Ross J; Tittensor AM; Fox AP; Sanders MF
Epidemiol Infect; 1989 Oct; 103(2):333-57. PubMed ID: 2806418
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. I. Natural occurrence of myxomatosis.
Merchant JC; Kerr PJ; Simms NG; Robinson AJ
Epidemiol Infect; 2003 Feb; 130(1):113-21. PubMed ID: 12613753
[TBL] [Abstract][Full Text] [Related]
13. Viral skin diseases of the rabbit.
Meredith AL
Vet Clin North Am Exot Anim Pract; 2013 Sep; 16(3):705-14. PubMed ID: 24018033
[TBL] [Abstract][Full Text] [Related]
14. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.
Camus-Bouclainville C; Gretillat M; Py R; Gelfi J; Guérin JL; Bertagnoli S
Emerg Infect Dis; 2011 Apr; 17(4):633-8. PubMed ID: 21470452
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
Marlier D; Mainil J; Boucraut-Baralon C; Linden A; Vindevogel H
J Comp Pathol; 2000; 122(2-3):115-22. PubMed ID: 10684680
[TBL] [Abstract][Full Text] [Related]
16. A case of low success of blind vaccination campaigns against myxomatosis and rabbit haemorrhagic disease on survival of adult European wild rabbits.
Rouco C; Moreno S; Santoro S
Prev Vet Med; 2016 Oct; 133():108-113. PubMed ID: 27663647
[TBL] [Abstract][Full Text] [Related]
17. Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.
Bárcena J; Morales M; Vázquez B; Boga JA; Parra F; Lucientes J; Pagès-Manté A; Sánchez-Vizcaíno JM; Blasco R; Torres JM
J Virol; 2000 Feb; 74(3):1114-23. PubMed ID: 10627521
[TBL] [Abstract][Full Text] [Related]
18. First report of myxomatosis in Mexico.
Licón Luna RM
J Wildl Dis; 2000 Jul; 36(3):580-3. PubMed ID: 10941750
[TBL] [Abstract][Full Text] [Related]
19. Myxomatosis in Australia and Europe: a model for emerging infectious diseases.
Kerr PJ
Antiviral Res; 2012 Mar; 93(3):387-415. PubMed ID: 22333483
[TBL] [Abstract][Full Text] [Related]
20. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host.
Stanford MM; Werden SJ; McFadden G
Vet Res; 2007; 38(2):299-318. PubMed ID: 17296158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
